Role of dietary beta-glucans in the prevention of the metabolic syndrome

Nutrition Reviews

Volumn 70, Issue 8, 2012, Pages 444-458

  Cloetens, Lieselotte ^a   Ulmius, Matilda ^a   Johansson Persson, Anna ^a   Åkesson, Björn ^a   Önning, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Appetite control; Dietary glucan; Hypertension; Metabolic syndrome; Prebiotic

Indexed keywords

BETA GLUCAN; CHOLECYSTOKININ; CHOLESTEROL; FRUCTAN; GALACTOSE OLIGOSACCHARIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; LIPID; PEPTIDE YY; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL CRAMP; ANTHROPOMETRY; ARTICLE; BACTERIAL METABOLISM; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; BLOATING; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL (TOPIC); DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; ENERGY METABOLISM; FLATULENCE; FOOD INTAKE; FUNCTIONAL FOOD; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC INDEX; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYDROLYSIS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTESTINE FLORA; LACTOBACILLUS; LIPID BLOOD LEVEL; MEAL; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OAT; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SATIETY; STROKE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

APPETITE; BETA-GLUCANS; DIETARY FIBER; ENERGY INTAKE; FERMENTATION; GASTROINTESTINAL TRACT; HUMANS; METABOLIC SYNDROME X; SATIETY RESPONSE;

EID: 84864335174     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00494.x     Document Type: Article

References (106)

1. Peterson DM. Genotype and environment effects on oat beta-glucan concentration. Crop Sci. 1991;31:1517-1520.
2. Lim HS, White PJ, Frey KJ. Genotypic effects on β-glucan content of oat lines grown in two consecutive years. Cereal Chem. 1992;69:262-265.
3. Yalçin E, Çelik S, Akar T, etal. Effects of genotype and environment on β-glucan and dietary fiber contents of hull-less barleys grown in Turkey. Food Chem. 2007;101:171-176.
4. Asp NG, Mattsson B, Önning G. Variation in dietary fibre, β-glucan, starch, protein, fat and hull content of oats grown in Sweden in 1987-1989. Eur J Clin Nutr. 1992;46:31-37.
5. Lee CJ, Horsley RD, Manthey FA, etal. Comparisons of β-glucan content of barley and oat. Cereal Chem. 1997;74:571-575.
6. Oscarsson M, Andersson R, Åman P, etal. Effects of cultivar, nitrogen fertilization rate and environment on yield and grain quality of barley. J Sci Food Agric. 1998;78:359-366.
7. Oscarsson M, Andersson R, Salomonsson AC, etal. Chemical composition of barley samples focusing on dietary fibre components. J Cereal Sci. 1996;24:161-170.
8. Wood PJ, Beer MU. Functional oat products. In: Mazza G, ed. Functional Foods. Biochemical and Processing Aspects. Lancaster, PA: Technomic Publishing; 1998:1-37.
9. U.S. Food and Drug Administration. Food labelling: health claims; oats and coronary heart disease. Final rule. Fed Regist. 1997;62:3584-3601.
10. U.S. Food and Drug Administration. Food labelling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Fed Regist. 2005;70:76150-76162.
11. EFSA (European Food Safety Authority) Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J. 2010:doi:10.2903/j.efsa.2010.1462.
12. Ripsin CM, Keenan JM, Jacobs DR, etal. Oat products and lipid lowering. A meta-analysis. JAMA. 1992;267:3317-3325.
13. Brown L, Rosner B, Willett WW, etal. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
14. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
15. Eckel RH, Alberti KG, Grundy SM, etal. The metabolic syndrome. Lancet. 2010;375:181-183.
16. Stern MP, Williams K, González-Villalpando C, etal. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27:2676-2681.
17. Ley RE, Turnbaugh PJ, Klein S, etal. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-1023.
18. Larsen N, Vogensen FK, van den Berg FW, etal. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5:e9085.
19. Bäckhed F. Changes in intestinal microflora in obesity: cause or consequence? J Pediatr Gastroenterol Nutr. 2009;48(Suppl 2):S56-S57.
20. Petruzzelli M, Moschetta A. Intestinal ecology in the metabolic syndrome. Cell Metab. 2010;11:345-346.
21. Sadiq Butt M, Tahir-Nadeem M, Khan MK, etal. Oat: unique among the cereals. Eur J Nutr. 2008;47:68-79.
22. Theuwissen E, Mensink RP. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav. 2008;94:285-292.
23. Cameron AJ, Boyko EJ, Sicree RA, etal. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity. 2008;16:2707-2716.
24. Nelson LH, Tucker LA. Diet composition related to body fat in a multivariate study of 203 men. J Am Diet Assoc. 1996;96:771-777.
25. Davis JN, Hodges VA, Gillham MB. Normal-weight adults consume more fiber and fruit than their age- and height-matched overweight/obese counterparts. J Am Diet Assoc. 2006;106:833-840.
26. Davis JN, Alexander KE, Ventura EE, etal. Inverse relation between dietary fibre intake and visceral adiposity in overweight Latino youth. Am J Clin Nutr. 2009;90:1160-1166.
27. US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 7th ed. Washington, DC: US Government Printing Office; 2010.
28. Becker W, Lyhne N, Pedersen AN, etal. Nordic nutrition recommendations 2004 - integrating nutrition and physical activity. Scand J Nutr. 2004;48:178-187.
29. Liu S, Willett WC, Manson JE, etal. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 2003;78:920-927.
30. Koh-Banerjee P, Franz M, Sampson L, etal. Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr. 2004;80:1237-1245.
31. Maki KC, Galant R, Samuel P, etal. Effects of consuming foods containing oat β-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr. 2007;61:786-795.
32. Queenan KM, Stewart ML, Smith KN, etal. Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J. 2007;26:6.
33. Liatis S, Tsapogas P, Chala E, etal. The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab. 2009;35:115-120.
34. Robitaille J, Fontaine-Bisson B, Couture F, etal. Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal women. Ann Nutr Metab. 2005;49:141-148.
35. Davy BM, Melby CL, Beske SD, etal. Oat consumption does not affect resting causal and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension. J Nutr. 2002;132:394-398.
36. Beck EJ, Tapsell LC, Batterham MJ, etal. Oat β-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr. 2010;103:1212-1222.
37. Dikeman CL, Murphy MR, Fahey GC. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr. 2006;136:913-919.
38. Isaksson G, Lundquist I, Ihse I. Effect of dietary fiber on pancreatic enzyme activity in vitro. Gastroenterology. 1982;82:918-924.
39. Marciani L, Gowland PA, Spiller RC, etal. Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. Am J Physiol Gastrointest Liver Physiol. 2001;280:G1227-G1233.
40. Hoad CL, Rayment P, Spiller RC, etal. In vivo imaging of intragastric gelation and its effect on satiety in humans. J Nutr. 2004;134:2293-2300.
41. Slavin J, Green H. Dietary fibre and satiety. Nutr Bull. 2007;32:32-42.
42. Suzuki K, Simpson KA, Minnion JS, etal. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J. 2010;57:359-372.
43. Beck EJ, Tapsell LC, Batterham MJ, etal. Increases in peptide Y-Y levels following oat β-glucan ingestion are dose-dependent in overweight adults. Nutr Res. 2009;29:705-709.
44. Beck EJ, Tosh SM, Batterham MJ, etal. Oat β-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects. Mol Nutr Food Res. 2009;53:1343-1351.
45. Vitaglione P, Lumaga RB, Stanzione A, etal β-glucan-enriched bread reduces energy intake and modifies plasma ghrelin and peptide YY concentrations in the short term. Appetite. 2009;53:338-344.
46. Lyly M, Liukkonen KH, Salmenkallio-Marttila M, etal. Fibre in beverages can enhance perceived satiety. Eur J Nutr. 2009;48:251-258.
47. Lyly M, Ohls N, Lähteenmäki L, etal. The effect of fibre amount, energy level, and viscosity of beverages containing oat fibre supplement on perceived satiety. Food Nutr Res. 2010;54:2149.
48. Peters HP, Boers HM, Haddeman E, etal. No effect of added β-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr. 2009;89:58-63.
49. Kim H, Behall KM, Vinyard B, etal. Short-term satiety and glycemic response after consumption of whole grains with various amounts of β-glucans. Cereal Food World. 2006;51:29-33.
50. Hlebowicz J, Darwiche G, Björgell O, etal. Effect of muesli with 4g oat beta-glucan on postprandial blood glucose, gastric emptying and satiety in healthy subjects: a randomized crossover trial. J Am Coll Nutr. 2008;27:470-475.
51. Willis HJ, Eldridge AL, Beiseigel J, etal. Greater satiety response with resistant starch and corn bran in human subjects. Nutr Res. 2009;29:100-105.
52. Astrup A. Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr. 2001;4:499-515.
53. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med. 1997;24:321-336.
54. Salmerón J, Ascherio A, Rimm EB, etal. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20:545-550.
55. Parillo M, Riccardi G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br J Nutr. 2004;92:7-19.
56. Brennan CS. Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res. 2005;49:560-570.
57. Jenkins AL, Jenkins DJA, Zdravkovic U, etal. Depression of the glycemic index by high levels of β-glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr. 2002;56:622-628.
58. Tapola N, Karvonen H, Niskanen L, etal. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2005;15:255-261.
59. Kim H, Stote KS, Behall KM, etal. Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, β-glucan. Eur J Nutr. 2009;48:170-175.
60. Granfeldt Y, Nyberg L, Björck I. Muesli with 4g oat β-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur J Clin Nutr. 2008;62:600-607.
61. Matthews DR, Hosker JP, Rudenski AS, etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologica. 1985;28:412-419.
62. Kabir M, Oppert JM, Vidal H, etal. Four-week low-glycemic index breakfast with modest amount of soluble fibers in type 2 diabetic men. Metabolism. 2002;51:819-826.
63. Cugnet-Anceau C, Nazare JA, Biorklund M, etal. A controlled study of consumption of β-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr. 2010;103:422-428.
64. Maki KC, Davidson MH, Witchger MS, etal. Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men. Int J Vitam Res. 2007;77:347-356.
65. Biörklund M, Holm J, Önning G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab. 2008;52:83-90.
66. Biörklund M, van Rees A, Mensink RP, etal. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: randomised dose-controlled trial. Eur J Clin Nutr. 2005;59:1272-1281.
67. Keogh GF, Cooper GJS, Mulvey TB, etal. Randomized, controlled crossover study of the effect of a highly β-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr. 2003;78:711-718.
68. Juntunen KS, Niskanen LK, Liukkonen KH, etal. Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects. Am J Clin Nutr. 2002;75:254-262.
69. Hallfrisch J, Behall KM. Mechanisms of the effects of grains on insulin and glucose responses. J Am Coll Nutr. 2000;19:S320-S325.
70. Regand A, Tosh SM, Wolever TMS, etal. Physiochemical properties of β-glucan in differently processed oat foods influence glycaemic response. J Agric Food Chem. 2009;57:8831-8838.
71. Ludwig DS. The glycemic index: physiological mechanisms related to obesity, diabetes, and cardiovascular disease. JAMA. 2002;74:229-237.
72. Thondre PS, Henry CJK. High-molecular-weight barley β-glucan in chapatis (unleavened Indian flatbread) lowers glycemic index. Nutr Res. 2009;29:480-486.
73. Mäkeläinen H, Anttila H, Sihvonen J, etal. The effect of β-glucan on the glycemic and insulin index. Eur J Clin Nutr. 2007;61:779-785.
74. Nazare JA, Normand S, Oste Triantafyllou A, etal. Modulation of the postprandial phase by β-glucan in overweight subjects: effects on glucose and insulin kinetics. Mol Nutr Food Res. 2009;53:361-369.
75. Battilana P, Ornstein K, Minehira K, etal. Mechanisms of action of β-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr. 2001;55:327-333.
76. Gemen R, de Vries JF, Slavin JL. Relationship between molecular structure of cereal dietary fiber and health effects: focus on glucose/insulin response and gut health. Nutr Rev. 2011;69:22-33.
77. Whelton SP, Hyre AD, Pedersen B, etal. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475-481.
78. Keenan JM, Pins JJ, Frazel C, etal. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J Fam Pract. 2002;51:369.
79. Pins JJ, Geleva D, Keenan JM, etal. Do whole-grain oat cereals reduce the need for anti-hypertensive medications and improve blood pressure control? J Fam Pract. 2002;51:353-359.
80. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512-519.
81. Bäckhed F, Ding H, Wang T, etal. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718-15723.
82. Cani PD, Delzenne NM. The role of gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15:1546-1558.
83. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc. 2010;69:434-441.
84. Gibson GR, Probert HM, Van Loo J, etal. Dietary modulation of the human colonic microbiota:updating the concept of prebiotics. Nutr Res Rev. 2004;17:259-275.
85. Wong JM, de Souza R, Kendall CW, etal. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235-243.
86. Roberfroid MB, Van Loo J, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998;128:11-19.
87. Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr. 1999;129:S1438-S1441.
88. Rao VA. The prebiotic properties of oligofructose at low intake levels. Nutr Res. 2001;6:843-848.
89. Bouhnik Y, Attar A, Joly FA, etal. Lactulose ingestion increases faecal bifidobacteria counts: a randomized double-blind study in healthy humans. Eur J Clin Nutr. 2004;58:462-466.
90. Bouhnik Y, Flourié B, D'Agay-Abensour L, etal. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 1997;127:444-448.
91. Na MH, Kim WK. Effects of xylooligosaccharides intake on faecal bifidobacteria, lactic acid and lipid metabolism in Korean young women. Kor J Nutr. 2007;40:154-161.
92. Cloetens L, De Preter V, Swennen K, etal. Dose-response effect of arabinoxylo-oligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr. 2008;27:512-518.
93. Cloetens L, Broekaert WF, Delaedt Y, etal. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr. 2010;103:703-713.
94. Jaskari J, Kontula P, Siitonen A, etal. Oat β-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl Microbiol Biotechnol. 1998;49:175-181.
95. Kedia G, Vázquez JA, Charalampopoulos D, etal. In vitro fermentation of oat bran obtained by debranning with a mixed culture of human fecal bacteria. Curr Microbiol. 2009;58:338-342.
96. Hughes SA, Shewry PR, Gibson GR, etal. In vitro fermentation of oat and barley derived β-glucans by human faecal microbiota. FEMS Microbiol Ecol. 2008;64:482-493.
97. Sayar S, Jannink JL, White PJ. Digestion residues of typical and high-β-glucan oat flours provide substrates for in vitro fermentation. J Agric Food Chem. 2007;55:5306-5311.
98. Kim HJ, White PJ. In vitro fermentation of oat flours from typical and high β-glucan oat lines. J Agric Food Chem. 2009;57:7529-7536.
99. Zhao J, Cheung PCK. Fermentation of β-glucans derived from different sources by bifidobacteria: evaluation of their bifidogenic effect. J Agric Food Chem. 2011;59:5986-5992.
100. Dongowski G, Huth M, Gebhardt E, etal. Dietary fiber-rich barley products beneficially affect the intestinal tract of rats. J Nutr. 2002;132:3704-3714.
101. Snart J, Bibiloni R, Grayson T, etal. Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat caecum. Appl Environ Microbiol. 2006;72:1925-1931.
102. Mårtensson O, Biörklund M, Lambo AM, etal. Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res. 2005;25:429-442.
103. Mitsou EK, Panopoulou N, Turunen K, etal. Prebiotic potential of barley derived β-glucan at low intake levels: a randomised, double-blinded, placebo-controlled clinical study. Food Res. Int. 2010;43:1086-1092.
104. Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis. 2002;34:S12-S18.
105. Woodmansey EJ. Intestinal bacteria and ageing. J Appl Microbiol. 2007;102:1178-1186.
106. TM). Food Chem Toxicol. 2010;48:422-428.